27.81

3.27% 0.88

After Hours: 27.81

Zai Lab Limited Adr (ZLAB)

Overview News Price History Option Chain Financials Why ZLAB Down? Discussions Forecast

Zai Lab Limited Adr stock is traded at $27.81, with a volume of 666.40K. It is up +3.27% in the last 24 hours and up +9.45% over the past month. Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Previous Close:

$26.93

Open:

$28.11

24h Volume:

666.40K

Relative Volume:

0.84

Market Cap:

$3.03B

Revenue:

$355.75M

Net Income/Loss:

$-270.85M

P/E Ratio:

-10.30

EPS:

-2.7

Net Cash Flow:

$-218.63M

1W Performance:

-0.11%

1M Performance:

+9.45%

6M Performance:

+53.56%

1Y Performance:

+28.69%

1-Day Range:

$27.28

$28.15

1-Week Range:

$26.07

$28.35

52-Week Range:

$13.48

$36.60

Zai Lab Limited Adr Stock (ZLAB) Company Profile

Name

Zai Lab Limited Adr

Sector

Healthcare (1177)

Industry

Biotechnology (679)

Phone

862161632588

Address

4560 JINKE ROAD, SHANGHAI

Employee

2,175

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

ZLAB's Discussions on Twitter

Compare ZLAB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ZLAB Zai Lab Limited Adr	27.81	3.03B	355.75M	-270.85M	-218.63M	-2.70
VRTX Vertex Pharmaceuticals Inc	481.16	123.91B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	722.07	78.94B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	657.97	39.98B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	278.25	35.89B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	119.94	28.75B	3.30B	-501.07M	1.03B	-2.1146

Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-14-23	Initiated	Morgan Stanley	Overweight
Aug-10-23	Initiated	Cantor Fitzgerald	Overweight
Jan-21-22	Initiated	Macquarie	Outperform
Oct-12-21	Initiated	Bernstein	Mkt Perform
Apr-28-20	Initiated	Goldman	Buy
Apr-15-20	Initiated	Guggenheim	Buy
Jul-12-19	Initiated	BofA/Merrill	Buy
Jul-05-19	Initiated	Macquarie	Outperform
Jan-29-19	Initiated	Credit Suisse	Outperform
Nov-21-18	Initiated	Jefferies	Buy
Jun-21-18	Resumed	Leerink Partners	Outperform
Feb-14-18	Upgrade	JP Morgan	Neutral → Overweight
Oct-16-17	Initiated	JP Morgan	Neutral
Oct-16-17	Initiated	Leerink Partners	Outperform

View All

Zai Lab Limited Adr Stock (ZLAB) Latest News

Feb 06, 2025

Forge Global Holdings Inc (FRGE)’s stock chart: A technical perspective - US Post News

Feb 06, 2025

Perimeter Solutions Inc (PRM)’s stock price in review: A technical analysis - US Post News

Feb 06, 2025

Was anything positive for Zai Lab Limited ADR (ZLAB) stock last session? - US Post News

Feb 06, 2025

United Natural Foods Inc (UNFI)’s stock performance: a year in review - US Post News

Feb 06, 2025

A stock that deserves closer examination: Cybin Inc (CYBN) - US Post News

Feb 06, 2025

Feb 05, 2025

Market Highlights: Zai Lab Limited ADR (ZLAB) Ends on a Low Note at 26.77 - The Dwinnex

Feb 05, 2025

Daily Progress: Concentrix Corp (CNXC) Drop -0.89, Closing at 48.99 - The Dwinnex

Feb 05, 2025

Market Watch: Rekor Systems Inc (REKR)’s Noteworthy Gain, Closing at 2.20 - The Dwinnex

Feb 05, 2025

Closing Strong: Selective Insurance Group Inc (SIGI) Ends at 83.49, Up 0.87 from Last Close - The Dwinnex

Feb 05, 2025

Feb 04, 2025

ZLAB (Zai Lab Limited ADR) may reap gains as insiders became active recently - Knox Daily

Feb 04, 2025